Population-based and family-based association study of 5′UTR polymorphism of the reelin gene and schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 137 B, Issue 1, 2005, Pages 51-55

  Goldberger, Céline ^a,b   Gourion, David ^a,b   Leroy, Sophie ^a,b   Schürhoff, Franck ^a,c   Bourdel, Marie Chantal ^a   Leboyer, Marion ^a,c   Krebs, Marie Odile ^a,b  

^a INSERM   (France)

^b Serv Hosp Univ de Sante Mentale   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Antipsychotic response; Association study; Neurodevelopment; Reelin; Schizophrenia

Indexed keywords

GENOMIC DNA; GLYCOPROTEIN; NEUROLEPTIC AGENT; REELIN; TRINUCLEOTIDE;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; FAMILY STUDY; FEMALE; FRANCE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; TRINUCLEOTIDE REPEAT;

5' FLANKING REGION; ADULT; ALLELES; ANTIPSYCHOTIC AGENTS; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX PROTEINS; FAMILY HEALTH; FEMALE; FRANCE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SERINE ENDOPEPTIDASES; TREATMENT OUTCOME; TRINUCLEOTIDE REPEATS;

EID: 23044452231     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30191     Document Type: Article

References (37)

1. Akahane A, Kunugi H, Tanaka H, Nanko S. 2002. Association analysis of polymorphic CGG repeat in 5′ UTR of the reelin and VLDLR genes with schizophrenia. Schizophr Res 58:37-41.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorder, 4th edn. Washington, DC: American Psychiatric Press.
3. Angelucci F, Mathe AA, Aloe L. 2000. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res 60:783-794.
4. Ballmaier M, Zoli M, Leo G, Agnati LF, Spano P. 2002. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: An emerging animal-based model of schizophrenia. Eur J Neurosci 15:1197-1205.
5. Bayer TA, Falkai P, Maier W. 1999. Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the "two hit hypothesis". J Psychiatr Res 33:543-548.
6. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C. 2001. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 8:723-742.
7. Curran T, D'Arcangelo G. 1998. Role of reelin in the control of brain development. Brain Re Brain Res Rev 26:285-294.
8. DeSilva U, D'Arcangelo G, Braden W, Chen J, Miao GG, Curran T, Green ED. 1997. The human reelin gene: Isolation, sequencing, and mapping on chromosome 7. Genome Res 7:157-164.
9. Duman RS, Malberg J, Nakagawa S. 2001. Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther 299: 401-407.
10. Eastwood SL, Harrison PJ. 2003. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: Towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry 769:821-831.
11. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD, Juvonen H, Varilo T, Arajarvi R, Kokko-Sahin ML, Lonnqvist J, Peltonen L. 2000. Genome-wide scan for schizophrenia in the Finnish population: Evidence for a locus on chromosome 7q22. Hum Mol Genet 9:1049-1057.
12. Fatemi SH. 2001. Reelin mutations in mouse and man: From reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol Psychiatry 6:129-133.
13. Fatemi SH, Earle JA, McMenomy T. 2000. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 5:654-663.
14. Fatemi SH, Kroll JL, Stary JM. 2001. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 12:3209-3215.
15. Carver DL, Holcomb JA, Christensen JD. 2000. Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum. J Clin Psychiatry 61:964-972.
16. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costan E, DiGiorgi Gerevini V. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch Gen Psychiatry 57:1061-1069.
17. Kay SR, Fizbein A, Opler LA. 1987. The positive and negative symptom scale (PANSS). Schizophr Bull 13:261-276.
18. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. 2004 Molecular abnormalities of the hippocampus in severe psychiatric illness: Postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9(6):609-620, 544.
19. Knapp M. 1999. The transmission/disequilibrium test and parental-genotype reconstruction: The reconstruction-combined transmission/ disequilibrium test. Am J Hum Genet 64:861-870.
20. Krebs MO, Guillin O, Bourdel MC, Schwartz JC, Olie JP, Poirier MF, Sokoloff P. 2000. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 5:558-562.
21. Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M, Paris Autism Research International Sibpair (PARIS) Study. 2002. Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism. Mol Psychiatry 7:801-804.
22. Lieberman JA, Alvir JM, Koreen A, Geisler S, Chakos M, Sheitman B, Woerner M. 1996. Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology 14:13S-21S.
23. Manji HK, Duman RS. 2001. Impairments of neuroplasticity and cellular resilience in severe mood disorders: Implications for the development of novel therapeutics. Psychopharmacol Bull Spring 35:5-49.
24. May PR, Dencker SJ, Hubbard JW, Midha KK, Lieberman RP. 1988. A systematic approach to treatment resistance in schizophrenic disorders In: Dencker S, Kulhanel F, editors. Treatment resistance in schizophrenia. Wiesbaden: Vieweg Verlag.
25. Murray RM. 1994. Neurodevelopmental schizophrenia: The rediscovery of dementia praecox. Br J Psychiatry Suppl 25:6-12.
26. Murray RM, Lewis SW. 1987. Is schizophrenia a neurodevelopmental disorder? Br Med J 295:681-682.
27. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
28. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859.
29. Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, Wassink TH, Schneider C, Melmed R, Trillo S, Montecchi F, Palermo M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Conciatori M, Marino R, Quattrocchi CC, Baldi A, Zelante L, Gasparini P, Keller F, Collaborative Linkage Study of Autism. 2001. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 6:150-159.
30. Raymond M, Rousset F. 1995. GENEPOP (version 1.2): Population genetics software for exact tests and oecumenicism. J Heredity 86:248-249.
31. Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E, Ernfors P, Ibanez CF. 1998. BDNF regulates reelin expression end Cajal-Retzius cell development in the cerebral cortex. Neuron 21:305-315.
32. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Aim Hum Genet 59:97-105.
33. Van Kammen DP, Kelley ME, Yao JK, Gilbertson MW, Gurklis JA, Inosaka T, Saito H, Peters JL, Sato M. 1996. Predicting haloperidol treatment response in chronic schizophrenia. Psychiatry Res 64:47-58.
34. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J. 2002. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944-39952.
35. Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
36. Weinberger DR. 1995. From neuropathology to neurodevelopment. Lancet 346:552-557.
37. Zipursky RB, Zhang-Wong J, Lambe EK, Bean G, Beiser M. 1998. MRI correlates of treatment response in first episode psychosis. Schizophr Res 27(30):81-90.